UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

   FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

    Date of Report (Date of earliest event reported): May 25, 2017

 

Rowan Companies plc

(Exact name of registrant as specified in its charter)

 

England and Wales

(State or Other Jurisdiction of

Incorporation or Organization)

1-5491

(Commission File Number)

 

98-1023315

(I.R.S. Employer

Identification Number)

     

2800 Post Oak Boulevard

Suite 5450

Houston, Texas
(Address of Principal Executive Offices)

 

 77056-6189

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (713) 621-7800

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

 

Director Retirements; Appointment of Chairman. As previously disclosed, Sir Graham Hearne (Chairman) and Mr. P. Dexter Peacock did not stand for re-election and retired from the Board of Directors (the “Board”) on May 25, 2017 at the end of their regular terms. The Board has appointed William E. Albrecht as the independent, non-executive Chairman of the Board effective May 25, 2017. Mr. Albrecht will receive an additional retainer of $150,000 as Chairman of the Board.

 

Amended and Restated 2013 Rowan Companies plc Incentive Plan. As previously disclosed, the 2013 Rowan Companies plc Incentive Plan (the “2013 Plan”) was initially approved by shareholders at the annual general meeting of shareholders held on April 26, 2013. In February 2017, the Compensation Committee recommended to the Board, and the Board approved and adopted, additional amendments to the 2013 Plan, subject to shareholder approval. As shown under Proposal 10 below, the Amended and Restated 2013 Plan (the “Plan”) was approved by shareholders, and became effective at the annual general meeting held on May 25, 2017. The description of the Plan is qualified in its entirety by reference to the full text of the Plan included as Exhibit I to the Company’s definitive Proxy Statement filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2017 (the “Proxy Statement”) and is incorporated herein by reference.

 

The 2013 Plan was amended in the following respects:

 

To increase the aggregate number of Class A ordinary shares with respect to which awards may be granted under the Plan, such that the total number of shares available for grant under the Plan is 11,125,258 (a net increase of 2,174,572 new shares added to the 8,950,686 shares which remained available for grant under the Plan as of December 31, 2016).

 

To provide that the number of ordinary shares available for grant under the Plan will be reduced by one share for each share subject to any option or share appreciation right, and 1.91 shares for each share subject to a full value award, in each case, granted under the Plan on or after the effective date of the Plan.

 

To list material terms of the performance goals that may apply to awards granted under the Plan intended to qualify as performance -based compensation under Section 162(m) of the U.S. Internal Revenue Code.

 

New Restricted Share Unit Award Notice for Non-Employee Directors. A new form of award notice was approved pursuant to which non-deferred share units (“RSUs”) may be issued to non-employee directors. The form of non-deferred RSU notice provides that the non-deferred RSUs will vest and be settled in full upon the earlier of (a) the first annual meeting of the Company’s shareholders to occur following the grant date and (b) the one-year anniversary of the applicable grant date, subject to the holder’s continued service as a director through the applicable vesting date, and further subject to accelerated vesting of such RSUs upon the holder’s death.  In addition, pursuant to the award notice, the RSUs are non-transferable other than in accordance with the terms of the Plan.  A copy of the form of award notice is filed as Exhibit 10.1 to this Current Report on Form 8-K, and is incorporated herein by reference.

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

The final voting results on each of the matters submitted to a vote of shareholders during the 2017 Annual General Meeting held on May 25, 2017 (the “Meeting”) are shown below. As of the record date, March 29, 2017, there were 126,135,187 Class A Ordinary Shares (“Shares”) outstanding and entitled to vote at the Meeting. The holders of a total of 102,743,106 Shares (81.45%) were present in person or by proxy at the Meeting, thereby reaching quorum. All of the proposals were approved with the requisite vote.

 

Proposal 1a – To re-elect by ordinary resolution William E. Albrecht as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
93,393,987 1,167,192 65,404 8,116,523

 

Proposal 1b – To re-elect by ordinary resolution Thomas P. Burke as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
93,762,991 821,262 42,330 8,116,523

 

Proposal 1c – To re-elect by ordinary resolution Thomas R. Hix as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
92,684,375 1,899,212 42,996 8,116,523

 

Proposal 1d – To elect by ordinary resolution Jack B. Moore as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
93,912,854 670,642 43,087 8,116,523

 

Proposal 1e – To elect by ordinary resolution Thierry Pilenko as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
94,174,751 370,244 81,588 8,116,523

 

Proposal 1f – To re-elect by ordinary resolution Suzanne P. Nimocks as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
93,248,006 1,336,277 42,300 8,116,523

 

Proposal 1g – To re-elect by ordinary resolution John J. Quicke as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
92,822,489 1,761,600 42,494 8,116,523

 

 

 

 

Proposal 1h – To re-elect by ordinary resolution Tore I. Sandvold as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
92,850,416 1,694,723 81,444 8,116,523

 

Proposal 1i – To elect by ordinary resolution Charles L. Szews as director of the Company for a term to expire at the annual general meeting of shareholders to be held in 2018:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
93,379,153 1,203,821 43,609 8,116,523

 

Proposal 2 – To approve, as a non-binding advisory resolution, the Company’s named executive officer compensation as reported in the 2017 proxy statement (in accordance with requirements applicable to companies subject to SEC reporting requirements under the Exchange Act):

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
91,482,653 3,073,633 70,297 8,116,523

 

Proposal 3 – To approve, as a non-binding advisory resolution, the frequency of future advisory votes, selecting among once every year, every two years or every three years, on the compensation of the NEOs pursuant to the compensation disclosure rules of the SEC:

 

Every year Every two years Every three years Abstain
93,001,441 126,844 1,452,243 46,055

 

Proposal 4 – To approve the Company’s directors’ remuneration policy:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
92,130,887 2,436,448 59,248 8,116,523

 

Proposal 5 – To approve, as a non-binding advisory resolution, the Company’s directors’ remuneration report for the year ended December 31, 2016, excluding the directors’ remuneration policy:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
89,926,230 4,640,448 59,905 8,116,523

 

Proposal 6 – To receive the Company’s U.K. annual report and accounts for the year ended December 31, 2016:

 

Votes For Votes Against Votes Abstaining
101,943,911 390,460 408,735

 

Proposal 7 – To ratify the Audit Committee’s appointment of Deloitte & Touche LLP as the Company’s U.S. independent registered public accounting firm for 2017:

 

Votes For Votes Against Votes Abstaining
100,589,962 2,060,693 92,451

 

 

 

 

Proposal 8 – To re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the U.K. Companies Act 2006 (the “Companies Act”):

 

Votes For Votes Against Votes Abstaining
100,716,995 1,930,064 96,047

 

Proposal 9 – To authorize the Audit Committee to determine the remuneration of Deloitte U.K., in its capacity as the Company’s U.K. statutory auditor:

 

Votes For Votes Against Votes Abstaining
101,076,074 1,550,560 116,472

 

Proposal 10 – To approve an amendment to the 2013 Rowan Companies plc Incentive Plan:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
92,324,824 2,255,318 46,441 8,116,523

 

Proposal 11 – To approve forms of share repurchase contracts and repurchase counterparties:

 

Votes For Votes Against Votes Abstaining
97,170,115 4,462,226 1,110,765

 

Proposal 12 – To authorize the Board, in accordance with section 551 of the Companies Act, to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for or convert any security into shares in the Company:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
92,688,100 1,886,814 51,669 8,116,523

 

Proposal 13 – To authorize the Board, by special resolution, in accordance with section 570 of the Companies Act, to allot equity securities (as defined in section 560 of the Companies Act) pursuant to the authority contemplated by the ordinary resolution included in Proposal 12 for cash without the rights of pre-emption provided by section 561 of the Companies Act:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
92,893,162 1,680,599 52,822 8,116,523

 

Proposal 14 – To authorize the Board, by special resolution, in accordance with section 570 of the Companies Act, to allot equity securities (as defined in section 560 of the Companies Act) pursuant to the authority contemplated by the ordinary resolution included in Proposal 12 for cash without the rights of pre-emption provided by section 561 of the Companies Act in connection with an acquisition or specified capital investment:

 

Votes For Votes Against Votes Abstaining Broker Non-Votes
93,703,298 867,037 56,248 8,116,523

 

(d) In accordance with the recommendation of the Board, the Company’s shareholders voted, on an advisory basis, in favor of holding future advisory votes to approve the Company’s named executive officer compensation every year. Based on the recommendation of the Board, the Company will include an advisory shareholder vote to approve the Company’s named executive officer compensation in its proxy materials on an annual basis until the next required advisory vote on the frequency of shareholder votes to approve the Company’s named executive officer compensation, which will occur no later than the Company’s annual general meeting of shareholders in 2023.

 

 

 

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No. Description
     
10.1*+  

Form of Non-Employee Director Non-Deferred Restricted Share Unit Notice

 

10.2  

Amended and Restated 2013 Rowan Companies plc Incentive Plan (incorporated by reference to Exhibit I of the Proxy Statement)

 

10.3   Form of Share Repurchase Contract and Form of Rule 10b5-1 Repurchase Plan (incorporated by reference to Exhibits II and III, respectively, of the Proxy Statement)

 

* Filed herewith

 

+ Compensatory plan or arrangement

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: May 25, 2017

Rowan Companies plc
   
  By:  /s/ Mark F. Mai
    Mark F. Mai
Executive Vice President, General Counsel and Company Secretary

 

 

 

 

 

Index to Exhibits

 

  

Exhibit No. Description

 

10.1*+  

Form of Non-Employee Director Non-Deferred Restricted Share Unit Notice

 

10.2  

Amended and Restated 2013 Rowan Companies plc Incentive Plan (incorporated by reference to Exhibit I of the Proxy Statement)

 

10.3   Form of Share Repurchase Contract and Form of Rule 10b5-1 Repurchase Plan (incorporated by reference to Exhibits II and III, respectively, of the Proxy Statement)

 

* Filed herewith

 

+ Compensatory plan or arrangement

 

 

 

 

 

 

Exhibit 10.1

 

2017 Non-deferred NED RSU Notice

 

2013 ROWAN COMPANIES PLC INCENTIVE PLAN

NON-EMPLOYEE DIRECTOR NON-DEFERRED RESTRICTED SHARE UNIT NOTICE

 

1. Grant of Restricted Share Units . Pursuant to Annex 1 to the 2013 Rowan Companies plc Incentive Plan as amended (the “ Plan ”), upon and subject to the conditions described in this Non-Employee Director Non-deferred Restricted Share Unit Notice (this “ Notice ”) and Annex 1 to the Plan, Rowan Companies plc, a public limited company incorporated under English law (the “ Company ”), hereby grants to ___________ (the “ Participant ”), effective as of _________ (the “ Grant Date ”), ___________ restricted share units (the “ RSUs ” and such award, the “ Grant ”). Each RSU is granted with a tandem Dividend Equivalent, which shall entitle the Participant to receive payments in accordance with Section 5 below. All capitalized terms used but not otherwise defined herein shall have the meanings set forth in the Plan.

 

2. Incorporation of the Plan . References in this Notice to the Plan shall be taken to mean Annex 1 to the Plan. The Plan is hereby incorporated herein by this reference. In the event of any conflict between the terms of this Notice and the Plan, the terms of the Plan shall control.

 

3. Vesting Schedule; Forfeiture; Payment .

 

(a) The Grant shall vest and become non-forfeitable with respect to all of the RSUs subject thereto on the earlier of (i) the date of the first (1st) annual general meeting of the Company’s shareholders to occur following the Grant Date or (ii) the one (1) year anniversary of the Grant Date (such date, the “ Vesting Date ”), subject to the Participant’s continued service as a Director through the Vesting Date; provided, however, that if the Participant incurs a Director Termination (as defined below) due to the Participant’s death prior to the Vesting Date, the Grant shall vest in full with respect to all RSUs (to the extent not then-vested) upon such Director Termination and shall be payable in accordance with Section 3(c) below.

 

(b) Subject to Section 3(a) above, if the Participant resigns as a Director, is removed as a Director or ceases to provide services as a Director for any reason (each, a “ Director Termination ”), the Grant (to the extent not then-vested, after taking into account any accelerated vesting that occurs in connection with such Director Termination, if any) shall be forfeited as of the date of such Director Termination, unless determined otherwise by the Committee. For the avoidance of doubt, upon the Participant ceasing to provide services as a Director for any reason, unless otherwise provided in this Notice or another written agreement between the Company and the Participant or otherwise determined by the Committee, no portion of the RSUs which have not become vested as of the date the Participant ceases to provide services as a Director shall thereafter become vested.

 

(c) Payment to the Participant of amounts due in respect of any RSUs that vest in accordance herewith shall be made in Shares or, as determined by the Committee in its discretion, in cash or a combination of Shares and cash, on the earliest to occur of: (i) the Vesting Date, and (ii) the Participant’s death. The Company shall distribute such Shares and/or cash to the Participant (or his or her estate, as applicable) within thirty (30) days after the applicable event requiring such distribution. If payment of the RSUs is made in Shares, the Committee may require the Participant to pay the nominal value for such Shares.

 

4. e stablishment of Account . The Company shall maintain an appropriate bookkeeping record (the “ RSU Account ”) that from time to time will reflect the Participant’s name, the number of RSUs granted to the Participant (and their vested status) and the Fair Market Value of such RSUs. The Fair Market Value of one (1) RSU shall equal the FMV Per Share. The RSUs granted hereby shall be credited to the Participant’s RSU Account effective as of the Grant Date.

 

 

 

 

5. Dividends . Each RSU granted hereunder is hereby granted in tandem with a corresponding Dividend Equivalent, which Dividend Equivalent shall remain outstanding from the Grant Date until the earlier of the settlement or forfeiture of the RSU to which it corresponds. Each Dividend Equivalent shall entitle the Participant to receive an additional amount of RSUs with an aggregate Fair Market Value equal to the product of (a) the per share amount of any cash dividend declared by the Company and (b) the number of Shares underlying the RSUs that are outstanding on the date on which the dividend is paid. Such additional RSUs shall be credited to the Participant’s RSU Account and the Shares underlying such additional RSUs shall be payable as and when the RSUs vest and are paid to the Participant. Any Dividend Equivalents that accrue prior to the settlement of the RSUs shall not accrue interest. Upon the forfeiture of an RSU, the Dividend Equivalent (and any RSUs credited to the Participant’s RSU Account in respect thereof) with respect to such forfeited RSU shall also be forfeited. The Dividend Equivalents and any Shares that may become distributable in respect thereof shall be treated separately from the RSUs and the rights arising in connection therewith for purposes of Code Section 409A (including for purposes of the designation of the time and form of payments required by Code Section 409A).

 

6. Responsibility for Taxes . The Participant acknowledges that, regardless of any action by the Company, the ultimate liability for all United Kingdom and/or United States federal, state, local and other taxes, foreign taxes, income taxes, social insurance taxes, payroll taxes, fringe benefits taxes, payments on account or other tax-related items related to the Participant's participation in the Plan and legally applicable to the Participant (collectively, the “ Tax-Related Items ”) is and remains the sole responsibility of the Participant's and is not the responsibility of the Company.

 

The Participant further acknowledges that the Company (i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs or Dividend Equivalents, including, but not limited to, the grant of the RSUs and tandem Dividend Equivalents, the issuance of Shares or payment of cash in respect thereof, the subsequent sale of Shares acquired pursuant to such issuance and the receipt of any dividends with respect to such Shares, and (ii) are under no obligation to structure the terms of the grant or any other aspect of the RSUs or the Dividend Equivalents to reduce or eliminate the Participant's liability for Tax-Related Items or achieve any particular tax result.

 

Further, the Participant acknowledges that, if the Participant is subject to Tax-Related Items in more than one jurisdiction between the Grant Date and the date of any relevant taxable or tax withholding event, as applicable, the Company may withhold or account for Tax-Related Items in more than one jurisdiction.

 

The Participant acknowledges and agrees that the Company shall have the right to require the Participant to satisfy all obligations relating to the Tax-Related Items by one or a combination of the following, as determined in the discretion of the Company (or, with respect to clauses (c) and (d) below, as determined in the discretion of the Committee):

 

(a) withholding from the Participant's cash compensation to be paid to the Participant by the Company, including any cash payment made pursuant to the RSUs (if the RSUs are paid in cash) and/or the Dividend Equivalents;

 

  2  

 

 

(b) withholding from proceeds of the sale of Shares acquired upon payment of the RSUs (if the RSUs are paid in Shares) either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant's behalf and without consent from the Participant);

 

(c) selling or transferring to the employee benefit trust established by the Company a number of Shares that would otherwise be issued upon payment of the RSUs (if the RSUs are paid in Shares); or

 

(d) withholding an appropriate number of Shares to be issued upon payment of the RSUs (if the RSUs are paid in Shares).

 

Notwithstanding anything herein to the contrary, unless the Committee determines otherwise, any withholding obligations relating to the Tax-Related Items, up to the applicable minimum statutory withholding amount or other applicable amount, will be satisfied by reducing the number of Shares issuable to the Participant in respect of the RSUs. For the avoidance of doubt, if the obligation for Tax-Related Items is satisfied by withholding Shares otherwise issuable pursuant to the RSUs, for tax purposes, the Participant shall be deemed to have been issued the full number of Shares subject to the RSUs, notwithstanding that number of the Shares withheld for the purpose of paying the Tax-Related Items. The Participant acknowledges and agrees that the Company shall have the authority and the right to deduct or withhold, or to require the Participant to pay to the Company an amount sufficient to satisfy all Tax-Related Items that arise in connection with the RSUs and the Dividend Equivalents.

 

For Participants subject to tax in the United Kingdom, if payment or withholding of the income tax due in connection with the RSUs is not made within ninety (90) days of any event giving rise to the income tax liability or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 (the “ Due Date ”), the amount of any uncollected income tax will constitute a benefit to the Participant on which additional income tax (and national insurance contributions (“ NICs ”), to the extent applicable) will be payable. The Company may recover any such additional income tax and NICs at any time thereafter by any of the means referred to herein or otherwise permitted under the Plan. The Participant will also be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime.

 

7. Adjustment .     The Participant acknowledges and agrees that the RSUs and Dividend Equivalents are subject to adjustment upon certain events as set forth in the Plan.

 

8. Participant’s Directorship . In consideration of the RSUs granted hereby, the Participant covenants with the Company that he or she shall remain a Director of the Company for at least six (6) months from the Grant Date.

 

9. Securities Laws .

 

(a)       The Participant acknowledges that the Plan and this Notice are intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act, and any and all regulations and rules promulgated by the Securities and Exchange Commission thereunder, as well as all applicable state securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted, only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Notice shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.

 

  3  

 

 

(b)       Notwithstanding any other provision of the Plan or this Notice, if the Participant is subject to Section 16 of the Exchange Act, then the Plan, the RSUs and this Notice shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable law, this Notice shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.

 

10. Conditions to Issuance of Shares . The Company shall not be required to issue or deliver any Shares or to make any book entries evidencing Shares issuable pursuant to the RSUs prior to fulfillment of the conditions set forth in Section 10.7 of the Plan.

 

11. Transfer of RSUs . Except as provided under Section 6 hereof, the RSUs, the Dividend Equivalents and all rights granted hereunder shall not be (i) assignable, saleable or otherwise transferable by the Participant other than by will or the laws of descent and distribution or pursuant to a domestic relations order or (ii) subject to any encumbrance, pledge or charge of any nature. Any purported assignment, pledge, attachment, sale, transfer, encumbrance or other charge of the RSUs or the Dividend Equivalents in violation of this Section 11 shall be void and of no force or effect. Without limiting the generality of the foregoing, the RSUs and the Dividend Equivalents shall be subject to the restrictions on transferability set forth in Section 10.8 of the Plan (“ Transferability ”).

 

12. Severability . In the event that any provision of this Notice shall be held illegal, invalid, or unenforceable for any reason, such provision shall be fully severable and shall not affect the remaining provisions of this Notice, and this Notice shall be construed and enforced as if the illegal, invalid or unenforceable provision had never been included herein.

 

13. Certain Restrictions . By accepting the RSUs granted under this Notice, the Participant acknowledges that he or she will enter into such written representations, warranties and notices and execute such documents as the Company may reasonably request in order to comply with the terms of this Notice or the Plan, or securities laws or any other applicable laws, rules or regulations, or as are otherwise deemed necessary or appropriate by the Company and/or the Company’s counsel.

 

14. Recoupment .   Notwithstanding any provision of this Notice to the contrary, the Participant acknowledges that the Committee may, in its sole discretion and in accordance with the terms of the Plan:

 

(a)       recoup from the Participant all or a portion of the Shares issued (or cash paid) and/or the Shares or payments made in respect of Dividend Equivalents under this Notice if the Company’s reported financial or operating results are materially and negatively restated within five (5) years of the issuance of such Shares or payment of such amounts, as applicable; and

 

(b)       recoup from the Participant if, in the Committee’s judgment, the Participant engaged in conduct which was fraudulent, negligent or not in good faith, and which disrupted, damaged, impaired or interfered with the business, reputation or employees of the Company or its Affiliates or which caused a subsequent adjustment or restatement of the Company’s reported financial statements, all or a portion of the Shares issued (or cash paid) and/or the payments made in respect of Dividend Equivalents under this Notice within five (5) years of such conduct.

 

  4  

 

 

In addition, to the extent determined by the Company in its discretion to be applicable to the Participant, the RSUs and/or the Dividend Equivalents, as applicable, shall be subject to the requirements of (i) Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (regarding recovery of erroneously awarded compensation) and any rules and regulations thereunder, (ii) similar rules under the laws of any other jurisdiction and (iii) any policies adopted by the Company to implement such requirements.

 

Any Shares subject to recoupment may be transferred to the employee benefit trust established by the Company, and the Participant agrees to execute any documents necessary to effectuate such transfer.

 

15. Amendment and Termination . Except as otherwise provided in the Plan or this Notice, no amendment of this Notice or the RSUs that adversely affects the Participant’s rights hereunder in any material respect or termination of this Notice shall be made by the Company without the consent of the Participant.

 

16. Data Privacy . The Participant explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this Notice and any other grant materials by and among the Company and its Affiliates (collectively, the “ Company Group ”) for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Plan.

 

The Participant understands that the Company Group may hold certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, title, any Shares or directorships held in the Company Group, details of any RSUs, Dividend Equivalents or any other entitlement to shares awarded, canceled, exercised, vested, unvested or outstanding in the Participant’s favor, for the exclusive purpose of implementing, administering and managing the Plan (collectively, “ Data ”).

 

The Participant understands that Data will be transferred to such Plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The recipients of Data may be located in the United States or elsewhere, and the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. The Participant may request a list with the names and addresses of any potential recipients of Data by contacting the Company’s Secretary. The Participant authorizes the Company Group and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of implementing, administering and managing his or her participation in the Plan. Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan. The Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Company’s Secretary. Further, the Participant is providing his or her consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, his or her service with the Company will not be adversely affected; the only adverse consequence of refusing or withdrawing the Participant's consent is that the Company would not be able to grant the RSUs or other equity awards to the Participant or administer or maintain such awards. Therefore, the Participant’s refusal or withdrawal of his or her consent may affect the Participant’s ability to participate in the Plan. For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant may contact the Company’s Secretary.

 

  5  

 

 

17. Code Section 409A; No Guarantee of Tax Consequences . This award of RSUs and Dividend Equivalents is intended to comply with Code Section 409A and the provisions hereof shall be interpreted and administered consistently with such intent. Notwithstanding any provision of the Plan or this Notice to the contrary, if at any time the Committee determines, in its sole discretion, that this award of RSUs or Dividend Equivalents (or any portion thereof) may not be compliant with Code Section 409A, the Committee shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan or this Notice, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Committee determines are necessary or appropriate to provide for either the RSUs and Dividend Equivalents to be exempt from the application of Code Section 409A or to comply with the requirements of Code Section 409A; provided, however, that this Section 17 shall not create any obligation on the part of the Company to adopt any such amendment, policy or procedure or take any such other action, nor shall the Company have any liability for failing to do so. The Company makes no commitment or guarantee to the Participant that any federal or state tax treatment will apply or be available to any person eligible for benefits under this Notice.

 

18. No Advice Regarding Grant . The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant's participation in the Plan, the grant, vesting and/or payment of the RSUs or Dividend Equivalents, and/or the acquisition or disposition of the Shares subject to the RSUs. The Participant is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.

 

19. Successors and Assignees; Binding Effect . The Company may assign any of its rights under this Notice to single or multiple assignees. Subject to the restrictions on transfer set forth herein, this Notice shall be binding upon and inure to the benefit of any assignees of or successors to the Company, the Participant and all persons lawfully claiming under the Participant.

 

20. Governing Law . This Notice shall be governed by, and construed in accordance with, the laws of the United States and the State of Texas, without regard to conflict of laws principles, except to the extent that the Act or the laws of England and Wales mandatorily apply.

 

21. Imposition of Other Requirements . The Company reserves the right to impose other requirements on the Participant's participation in the Plan, the RSUs, Dividend Equivalents and any Shares issued under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

 

  6  

 

 

22. Waiver . A waiver by the Company of breach of any provision of this Notice shall not operate or be construed as a waiver of any other provision of this Notice, or of any subsequent breach of any other provision of this Notice by the Participant or any other person.

 

****

 

 

 

  7  

 

2017 Non-deferred NED RSU Notice

 

 

2013 ROWAN COMPANIES PLC INCENTIVE PLAN

NON-EMPLOYEE DIRECTOR NON-DEFERRED RESTRICTED SHARE UNIT NOTICE

 

 

 

By signing below, the Participant agrees to be bound by the terms and conditions of the Plan and this Notice. The Participant hereby agrees to accept as binding, conclusive and final all decisions and/or interpretations of the Committee upon any questions arising under the Plan or relating to the RSUs and the Dividend Equivalents.

 

 

____________________________________

Name

 

 

 

Please sign and return in the enclosed envelope.